Pacira BioSciences, Inc.
US ˙ NasdaqGS ˙ US6951271005

SecurityPCRX / Pacira BioSciences, Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership7,017,119 shares
Ownership 15.20%
BlackRock, Inc. ownership in PCRX / Pacira BioSciences, Inc.

2025-04-28 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7,017,119 shares of Pacira BioSciences, Inc. (US:PCRX). This represents 15.2 percent ownership of the company. In their previous filing dated 2024-01-19 , BlackRock, Inc. had reported owning 8,113,714 shares, indicating a decrease of -13.52 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2025-04-28 2025-04-28 13G/A 8,113,714 7,017,119 -13.52 15.20 -13.14
2024-01-19 2024-01-19 13G/A 7,250,908 8,113,714 11.90 17.50 10.76
2023-01-23 2023-01-23 13G/A 6,821,518 7,250,908 6.29 15.80 3.27
2022-01-27 2022-01-27 13G/A 6,821,518 6,821,518 0.00 15.30 0.00
2022-01-26 2022-01-26 13G/A 7,099,847 6,821,518 -3.92 15.30 -6.13
2021-02-05 2021-02-05 13G/A 7,004,499 7,099,847 1.36 16.30 -2.98
2020-02-10 2020-02-10 13G/A 6,758,949 7,004,499 3.63 16.80 3.70
2019-10-09 2019-10-09 13G/A 3,331,529 6,758,949 102.88 16.20 100.00
2019-02-11 2019-02-11 13G/A 3,292,397 3,331,529 1.19 8.10 0.00
2018-02-08 2018-02-08 13G/A 3,216,888 3,292,397 2.35 8.10 -5.81
2017-01-25 2017-01-25 13G/A 2,776,196 3,216,888 15.87 8.60 13.16
2016-01-27 2016-01-27 13G/A 2,776,196 7.60
2015-01-26 2015-01-26 13G/A 2,642,191 7.30
2014-01-30 2014-01-30 13G 2,182,927 6.50

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F PACIRA BIOSCIENCES COM 695127100 6,735,343 -328,937 -4.66 152,219 -16.74 0.0002
2026-02-12 2025-12-31 13F PACIRA BIOSCIENCES COM 695127100 7,064,280 -271,918 -3.71 182,824 -3.30 0.0031
2025-11-12 2025-09-30 13F PACIRA BIOSCIENCES COM 695127100 7,336,198 -459,831 -5.90 189,054 1.46 0.0033
2025-08-12 2025-06-30 13F PACIRA BIOSCIENCES COM 695127100 7,796,029 142,666 1.86 186,325 -2.03 0.0035
2025-05-02 2025-03-31 13F PACIRA BIOSCIENCES COM 695127100 7,653,363 -56,456 -0.73 190,186 30.94 0.0040
2025-02-07 2024-12-31 13F PACIRA BIOSCIENCES COM 695127100 7,709,819 -77,580 -1.00 145,253 23.94 0.0029
2024-11-13 2024-09-30 13F PACIRA BIOSCIENCES COM 695127100 7,787,399 -219,427 -2.74 117,200 -48.84 0.0025
2024-08-13 2024-06-30 13F PACIRA BIOSCIENCES COM 695127100 8,006,826 101,670 1.29 229,075 -0.83 0.0052
2024-05-10 2024-03-31 13F PACIRA BIOSCIENCES COM 695127100 7,905,156 -209,095 -2.58 230,989 -15.63 0.0054
2024-02-13 2023-12-31 13F PACIRA BIOSCIENCES COM 695127100 8,114,251 607,254 8.09 273,775 18.87 0.0070
2023-11-13 2023-09-30 13F PACIRA BIOSCIENCES COM 695127100 7,506,997 25,528 0.34 230,315 -23.17 0.0066
2023-08-11 2023-06-30 13F PACIRA BIOSCIENCES COM 695127100 7,481,469 -31,959 -0.43 299,782 -2.23 0.0083
2023-05-12 2023-03-31 13F PACIRA BIOSCIENCES COM 695127100 7,513,428 261,983 3.61 306,623 9.52 0.0090
2023-02-13 2022-12-31 13F PACIRA BIOSCIENCES COM 695127100 7,251,445 96,867 1.35 279,978 -26.43 0.0088
2022-11-14 2022-09-30 13F PACIRA BIOSCIENCES COM 695127100 7,154,578 43,517 0.61 380,553 -8.21 0.0129
2022-08-12 2022-06-30 13F PACIRA BIOSCIENCES COM 695127100 7,111,061 140,506 2.02 414,576 -22.07 0.0133
2022-05-12 2022-03-31 13F PACIRA BIOSCIENCES COM 695127100 6,970,555 149,037 2.18 531,992 29.61 0.0143
2022-02-10 2021-12-31 13F PACIRA BIOSCIENCES COM 695127100 6,821,518 125,626 1.88 410,451 9.46 0.0105
2021-11-09 2021-09-30 13F PACIRA BIOSCIENCES COM 695127100 6,695,892 36,812 0.55 374,971 -7.20 0.0105
2021-08-11 2021-06-30 13F PACIRA BIOSCIENCES COM 695127100 6,659,080 -514,407 -7.17 404,073 -19.63 0.0112
2021-05-07 2021-03-31 13F PACIRA BIOSCIENCES COM 695127100 7,173,487 73,640 1.04 502,787 18.34 0.0148
2021-02-05 2020-12-31 13F PACIRA BIOSCIENCES COM 695127100 7,099,847 438,448 6.58 424,854 6.08 0.0136
2020-11-06 2020-09-30 13F PACIRA BIOSCIENCES COM 695127100 6,661,399 -360,575 -5.13 400,485 8.70 0.0148
2020-08-14 2020-06-30 13F PACIRA BIOSCIENCES COM 695127100 7,021,974 198,864 2.91 368,443 61.05 0.0147
2020-05-01 2020-03-31 13F PACIRA BIOSCIENCES COM 695127100 6,823,110 -181,389 -2.59 228,780 -27.90 0.0112
2020-02-13 2019-12-31 13F PACIRA BIOSCIENCES COM 695127100 7,004,499 245,550 3.63 317,302 23.31 0.0122
2019-11-08 2019-09-30 13F PACIRA BIOSCIENCES COM 695127100 6,758,949 3,438,973 103.58 257,313 78.21 0.0108
2019-08-22 2019-06-30 13F/A-1 PACIRA BIOSCIENCES COM 695127100 3,319,976 3,374 0.10 144,386 14.38 0.0062
2019-08-13 2019-06-30 13F PACIRA BIOSCIENCES COM 695127100 3,319,976 3,374 144,386
2019-05-09 2019-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 3,316,602 -14,927 -0.45 126,231 -11.93 0.0056
2019-02-08 2018-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 3,331,529 45,072 1.37 143,323 -11.27 0.0072
2018-11-09 2018-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 3,286,457 -22,603 -0.68 161,531 52.31 0.0070
2018-08-09 2018-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 3,309,060 81,149 2.51 106,055 5.47 0.0049
2018-05-09 2018-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 3,227,911 -64,486 -1.96 100,550 -33.10 0.0048
2018-02-09 2017-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 3,292,397 -28,496 -0.86 150,298 20.53 0.0072
2017-11-14 2017-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 3,320,893 -157,388 -4.52 124,700 -24.84 0.0063
2017-08-10 2017-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 3,478,281 294,494 9.25 165,914 14.28 0.0088
2017-05-12 2017-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 3,183,787 3,172,817 28,922.67 145,180 40,795.77 0.0080
2017-02-10 2016-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 10,970 -16,353 -59.85 355 -62.03 0.0005
2016-11-08 2016-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 27,323 23,316 581.88 935 592.59 0.0013
2016-08-10 2016-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 4,007 1,510 60.47 135 1.50 0.0002
2016-05-10 2016-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 2,497 1,376 122.75 133 54.65 0.0002
2016-02-11 2015-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 1,121 287 34.41 86 152.94 0.0001
2015-11-13 2015-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 834 -124 -12.94 34 -49.25 0.0001
2015-08-07 2015-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 958 -61 -5.99 67 -25.56 0.0001
2015-05-13 2015-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 1,019 0 0.00 90 0.00 0.0001
2015-02-09 2014-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 1,019 -12,400 -92.41 90 -93.08 0.0001
2014-10-29 2014-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 13,419 12,400 1,216.88 1,301 1,284.04 0.0019
2014-08-06 2014-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 1,019 124 13.85 94 51.61 0.0001
2014-05-02 2014-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 895 0 0.00 62 19.23 0.0001
2014-02-12 2013-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 895 0 0.00 52 20.93 0.0001
2013-11-12 2013-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 895 -289 -24.41 43 26.47 0.0001
2013-08-13 2013-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 1,184 1,184 34 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.